As of 10th June, Market Cap: Earkart Limited has a market capitalization of 164.00 Cr, categorizing it as a Micro Cap company.Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.Balance Sheet Snapshot: The reporting period is for March 2025, with Shareholder's Funds amounting to 19.92 Cr and Total Assets totaling 30.19 Cr.

Share Price | Earkart Limited Stock Analysis & Recommendation

Q: Why is Earkart Limited falling/rising?

As of 01-Sep, Earkart Limited's stock price is currently at 121.00, showing no change (0.00%). The stock's performance over various periods indicates a downward trend, with a year-to-date decline of 18.68%, which is significantly worse than the Sensex's decline of 9.71%. Over the past month, Earkart's stock has decreased by 13.57%, while the benchmark index has only fallen by 1.47%.Today's trading performance is described as inline with the sector, but there are concerning signs regarding investor participation. The delivery volume on August 31 was only 1,000 shares, which represents a 66.67% drop compared to the 5-day average delivery volume. Additionally, Earkart is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend.Overall, the combination of significant declines in stock performance, reduced investor participation, and trading below moving averages suggests that Earkart Limited's stock is experiencing downward pressure.

Q: What does Earkart do?

Overview: Earkart Limited operates in the healthcare services industry and is categorized as a micro-cap company.History: The incorporation year and any status changes are not provided, and there are no reported sales or profit figures for the latest quarter.Financial Snapshot: Most recent Net Sales: N/A Most recent Net Profit: N/A Market-cap value: INR 168 Cr (Micro Cap)Key Metrics: P/E: 34.00 Industry P/E: 112 Dividend Yield: 0.00% Debt-Equity: -0.34 Return on Equity: 7.66% Price-to-Book: 2.61Contact Details: Registrar Address: Not available. Phone: Not available. Email: Not available. Website: Not available.

Q: Who are the peers of the Earkart?

Peers: The peers of Earkart are Nureca, Take, Bilcare, Jeevan Scienti., Star Imaging, Choksi Laborator, QMS Medical, Aakaar Medical.Quality Snapshot: Excellent management risk is observed at Star Imaging and Aakaar Medical, while Average management risk is found at QMS Medical. Below Average management risk is noted for Nureca, Take, Bilcare, Jeevan Scienti., Choksi Laborator, and the rest. Growth is rated as Good for Bilcare, Choksi Laborator, and Aakaar Medical, while Below Average growth is seen in Nureca, Take, Jeevan Scienti., and the rest. Capital Structure is rated as Excellent for Star Imaging, Good for Aakaar Medical, and Below Average for Nureca, Take, Bilcare, Jeevan Scienti., Choksi Laborator, and the rest.Return Snapshot: The peer with the highest 1-year return is Jeevan Scienti. at 87.30%, while the lowest is QMS Medical with a return of 0.00%. Earkart's 1-year return is not available for comparison. Additionally, peers with negative six-month returns include Take and Earkart.

Technical Trend Update: Earkart witnessed a change in Technical Grade on 01 Sep 2026. Click here to discover latest technical change!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

3.0 k (15.38%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

21.95%

Held by 0 DIIs

Promoter

57.34%

Why is Earkart Limited falling/rising?

02-Sep-2026

As of 01-Sep, Earkart Limited's stock price is at 121.00, with an 18.68% year-to-date decline, significantly worse than the Sensex's 9.71% drop. The stock shows bearish trends with reduced investor participation and is trading below all moving averages.

View full answer

What does Earkart do?

01-Sep-2026

Earkart Limited is a micro-cap company in the healthcare services industry with no reported sales or profits for the latest quarter, a market cap of INR 168 Cr, and a P/E ratio of 34.00. Key financial metrics include a debt-equity ratio of -0.34 and a return on equity of 7.66%.

View full answer

Who are the peers of the Earkart?

01-Sep-2026

Earkart's peers include Nureca, Take, Bilcare, Jeevan Scientific, Star Imaging, Choksi Laborator, QMS Medical, and Aakaar Medical. Key insights show varying management risks and growth ratings, with Jeevan Scientific achieving the highest 1-year return at 87.30% and QMS Medical the lowest at 0.00%.

View full answer

Which are the latest news on Earkart?

01-Sep-2026

No latest news for Earkart found.

How big is Earkart?

11-Jun-2026

As of 10th June, Earkart Limited has a market capitalization of 164.00 Cr, classifying it as a Micro Cap company. There is no available financial data for Net Sales and Net Profit for the latest four quarters.

View full answer

When is the next results date for Earkart Limited?

27-May-2026

The next results date for Earkart Limited is 29 May 2026.

View full answer

Compare Earkart with Similar Stocks

Bilcare Star Imaging Take

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Healthcare Services

Market cap

INR 166 Cr (Micro Cap)

P/E

34.00

Industry P/E

116

Dividend Yield

0.00%

Debt Equity

-0.34

Return on Equity

7.66%

Price to Book

2.59

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

1.68%

6 Months

0.0%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Earkart for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Reg. 34 (1) Annual Report.

17-Jul-2026 | Source : BSE

Annual Report for the Financial Year 2025-26 of Earkart Limited

Shareholder Meeting / Postal Ballot-Scrutinizers Report

17-Jul-2026 | Source : BSE

Intimation of E-voting results and Report of scrutinizer of the 5th Annual General Meeting of the Member of the Earkart Limited

Shareholder Meeting / Postal Ballot-Outcome of AGM

15-Jul-2026 | Source : BSE

Further to our letter dated 23 June 2026 pertaining to date of intimation of 5th Annual General Meeting and pursuant to Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith summary of proceedings of 5th Annual General Meeting of the Company held on 15 July 2026 through Video Conferencing (VC)/ Other Audio Visual Means(OVAM).

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

6.80

Debt to EBITDA (avg)

0.58

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.72

Tax Ratio

31.96%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

21.95%

ROCE (avg)

26.47%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

116

Price to Book Value

2.59

EV to EBIT

18.80

EV to EBITDA

17.31

EV to Capital Employed

3.39

EV to Sales

2.68

PEG Ratio

Dividend Yield

ROCE (Latest)

18.05%

ROE (Latest)

7.66%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

KST

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Rohit Misra (55.04%)

Highest Public shareholder

Neomile Growth Fund- Series -i (16.92%)

Individual Investors Holdings

16.94%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Earkart"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 42.44% vs -5.35% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is 66.49% vs -44.11% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31.75",
          "val2": "22.29",
          "chgp": "42.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.21",
          "val2": "3.14",
          "chgp": "65.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.16",
          "val2": "0.39",
          "chgp": "-58.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.08",
          "val2": "1.85",
          "chgp": "66.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.41%",
          "val2": "14.09%",
          "chgp": "2.32%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Earkart"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 25.35% vs 35.78% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -28.34% vs 124.84% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "54.04",
          "val2": "43.11",
          "chgp": "25.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.36",
          "val2": "9.76",
          "chgp": "-14.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.54",
          "val2": "0.41",
          "chgp": "31.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.93",
          "val2": "6.88",
          "chgp": "-28.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.47%",
          "val2": "22.64%",
          "chgp": "-7.17%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26

Mar'26

Sep'25

Change(%)

Net Sales

31.75

22.29

42.44%

Operating Profit (PBDIT) excl Other Income

5.21

3.14

65.92%

Interest

0.16

0.39

-58.97%

Exceptional Items

0.00

Standalone Net Profit

3.08

1.85

66.49%

Operating Profit Margin (Excl OI)

16.41%

14.09%

2.32%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Mar 2026 is 42.44% vs -5.35% in Sep 2025

Standalone Net Profit

Growth in half year ended Mar 2026 is 66.49% vs -44.11% in Sep 2025

All Half Yearly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

54.04

43.11

25.35%

Operating Profit (PBDIT) excl Other Income

8.36

9.76

-14.34%

Interest

0.54

0.41

31.71%

Exceptional Items

0.00

Standalone Net Profit

4.93

6.88

-28.34%

Operating Profit Margin (Excl OI)

15.47%

22.64%

-7.17%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 25.35% vs 35.78% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is -28.34% vs 124.84% in Mar 2025

All Annual Results

Company CV

About Earkart Limited

Earkart Limited

Micro Cap

Healthcare Services

No Details Available.

Company Coordinates

No Company Details Available